Bisaro Paul

Bisaro Paul is listed in filings as Director at Myriad Genetics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Myriad Genetics, Inc. (MYGN), NONE, and Zoetis Inc (ZTS). The current snapshot covers public activity from Feb 20, 2025 to Jun 5, 2026. Reported amounts are shown as $27.6K to $151.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.